Cadherin 5 is Regulated by Corticosteroids and Associated with Central Serous Chorioretinopathy

被引:77
作者
Schubert, Carl [1 ]
Pryds, Anders [2 ]
Zeng, Shemin [3 ]
Xie, Yajing [1 ]
Freund, K. Bailey [4 ]
Spaide, Richard F. [4 ]
Merriam, John C. [1 ]
Barbazetto, Irene [4 ]
Slakter, Jason S. [4 ]
Chang, Stanley [1 ]
Munch, Inger C. [2 ]
Drack, Arlene V. [3 ]
Hernandez, Jasmine [3 ]
Yzer, Suzanne [1 ]
Merriam, Joanna E. [1 ]
Linneberg, Allan [5 ]
Larsen, Michael [2 ]
Yannuzzi, Lawrence A. [4 ]
Mullins, Robert F. [3 ]
Allikmets, Rando [1 ,6 ]
机构
[1] Columbia Univ, Dept Ophthalmol, New York, NY 10032 USA
[2] Univ Copenhagen, Dept Ophthalmol, Glostrup Hosp, Copenhagen, Denmark
[3] Univ Iowa, Dept Ophthalmol & Visual Sci, Carver Coll Med, Iowa City, IA 52242 USA
[4] Vitreous Retina Macula Consultants New York, New York, NY USA
[5] Capital Reg Denmark, Res Ctr Prevent & Hlth, Copenhagen, Denmark
[6] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA
关键词
CDH5; Cadherin; 5; central serous chorioretinopathy; genetic association; retinal disease; DIFFUSE RETINAL EPITHELIOPATHY; OPTICAL COHERENCE TOMOGRAPHY; HELICOBACTER-PYLORI; ENDOTHELIAL-CELLS; VE-CADHERIN; EXPRESSION; CHORIOCAPILLARIS; PERMEABILITY; RETINOPATHY; THERAPY;
D O I
10.1002/humu.22551
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Central serous chorioretinopathy (CSC) is characterized by leakage of fluid from the choroid into the subretinal space and, consequently, loss of central vision. The disease is triggered by endogenous and exogenous corticosteroid imbalance and psychosocial stress and is much more prevalent in men. We studied the association of genetic variation in 44 genes from stress response and corticosteroid metabolism pathways with the CSC phenotype in two independent cohorts of 400 CSC cases and 1,400 matched controls. The expression of cadherin 5 (CDH5), the major cell-cell adhesion molecule in vascular endothelium, was downregulated by corticosteroids which may increase permeability of choroidal vasculature, leading to fluid leakage under the retina. We found a significant association of four common CDH5 SNPs with CSC in male patients in both cohorts. Two common intronic variants, rs7499886:A>G and rs1073584:C>T, exhibit strongly significant associations with CSC; P=0.00012; odds ratio (OR)=1.5; 95%CI [1.2;1.8], and P=0.0014; OR=0.70; 95%CI [0.57;0.87], respectively. A common haplotype was present in 25.4% male CSC cases and in 35.8% controls (P=0.0002; OR=0.61, 95% CI [0.47-0.79]). We propose that genetically predetermined variation in CDH5, when combined with triggering events such as corticosteroid treatment or severe hormonal imbalance, underlie a substantial proportion of CSC in the male population.
引用
收藏
页码:859 / 867
页数:9
相关论文
共 50 条
  • [21] Retinal Vascular Reactivity in Central Serous Chorioretinopathy
    Piccolino, Felice Cardillo
    Lupidi, Marco
    Cagini, Carlo
    Fruttini, Daniela
    Nicolo, Massimo
    Eandi, Chiara Maria
    Tito, Silvia
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (11) : 4425 - 4433
  • [22] Central Serous Chorioretinopathy Associated with Rowatinex Usage
    Akyol-Salman, Ilknur
    Lece-Sertoz, Deniz
    Mumcu, Ugur
    Ates, Orhan
    Baykal, Orhan
    EURASIAN JOURNAL OF MEDICINE, 2009, 41 (03) : 197 - 199
  • [23] Central serous chorioretinopathy associated with adrenal myelolipoma
    Katsimpris, JM
    Vandoros, M
    Petropoulos, IK
    Andrikopoulos, P
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2003, 220 (03) : 199 - 203
  • [24] The Effect of Corticosteroids on Human Choroidal Endothelial Cells: A Model to Study Central Serous Chorioretinopathy
    Brinks, Joost
    van Dijk, Elon H. C.
    Habeeb, Mahmoud
    Nikolaou, Aikaterini
    Tsonaka, Roula
    Peters, Hendrika A. B.
    Sips, Hetty C. M.
    van de Merbel, Arjanneke F.
    de Jong, Eiko K.
    Notenboom, Robbert G. E.
    Kielbasa, Szymon M.
    van der Maarel, Silvere M.
    Quax, Paul H. A.
    Meijer, Onno C.
    Boon, Camiel J. F.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (13) : 5682 - 5692
  • [25] Photodynamic therapy for chronic central serous chorioretinopathy
    Ruiz-Moreno, Jose M.
    Lugo, Francisco L.
    Armada, Felix
    Silva, Rufino
    Montero, Javier A.
    Fernando Arevalo, J.
    Arias, Luis
    Gomez-Ulla, Francisco
    ACTA OPHTHALMOLOGICA, 2010, 88 (03) : 371 - 376
  • [26] Eplerenone treatment in chronic central serous chorioretinopathy
    Sampo, M.
    Soler, V.
    Gascon, P.
    Yin, G. Ho Wang
    Hoffart, L.
    Denis, D.
    Matonti, F.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2016, 39 (06): : 535 - 542
  • [27] Choroidal Vascular Reactivity in Central Serous Chorioretinopathy
    Piccolino, Felice Cardillo
    Lupidi, Marco
    Cagini, Carlo
    Fruttini, Daniela
    Nicolo, Massimo
    Eandi, Chiara Maria
    Tito, Silvia
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (10) : 3897 - 3905
  • [28] Central Serous Chorioretinopathy: Update on Pathophysiology and Treatment
    Nicholson, Benjamin
    Noble, Jason
    Forooghian, Farzin
    Meyerle, Catherine
    SURVEY OF OPHTHALMOLOGY, 2013, 58 (02) : 103 - 126
  • [29] ANTIANGIOGENICS IN CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH LASER IN CENTRAL SEROUS CHORIORETINOPATHY
    Chhablani, Jay
    Pichi, Francesco
    Silva, Rufino
    Casella, Antonio Marcelo
    Murthy, Hemanth
    Banker, Alay
    Nowilaty, Sawsan R.
    Carrai, Paola
    Nucci, Paolo
    Arevalo, J. Fernando
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (05): : 901 - 908
  • [30] Central Serous Chorioretinopathy after Rhinoplasty
    Moschos, Marilita M.
    Droutsas, Konstantinos
    Margetis, Ioannis
    CASE REPORTS IN OPHTHALMOLOGY, 2010, 1 (02): : 90 - 93